Navigation mit Access Keys

Search


Novel insights: How muscles change during endurance training

Endurance training is beneficial. Regular workouts not only improve physical fitness and well-being, but also trigger profound muscle remodeling. This is reflected in typical training effects: muscles fatigue less quickly,…


Biozentrum spin off ARTIDIS raised 8.8 Million Swiss Francs

“The closure of this financing round and the successful recruitment of 545 patients in our first clinical study at the University Hospital Basel this year is a huge success”, states Marija Plodinec, CEO of ARTIDIS. “We are…


Farewell Symposium for Prof. Erich Nigg, Director of the Biozentrum, on 1 February 2018

Many distinguished scientists who collaborated with Erich Nigg in his laboratories in Zurich, Lausanne, Geneva, Munich or Basel, or work in the same field as Erich Nigg, are invited to give a talk at the symposium. The…


Unique fingerprint: What makes nerve cells unmistakable?

Our brain consists of hundreds, if not thousands, of different types of nerve cells that control our brain functions due to their individual characteristics. But how do the different cell types manage to develop their…


Not too young to be a researcher - kids@science at the Biozentrum

The kids@science study week at the University of Basel, introduced in 2008, is very popular among the young researchers. This year, some 120 school children have applied to participate. At the end of January, 81 will receive…


New target to treat severe autoimmune disease

LRBA deficiency is a rare and severe autoimmune disorder that was first described in 2012. This disease is caused by a genetic defect in the LRBA gene and is characterized by an impaired immune response and autoimmunity.…


ERC Advanced Grant for Silvia Arber

The goal of the ERC Advanced Grants is to support established, leading principal investigators to pursue a groundbreaking and high-risk project. As all ERC grants, they are in high demand and therefore very competitive. This…


Biozentrum start-up NextImmune supported by Venture Kick

The company NextImmune , founded at the Biozentrum of the University of Basel in 2021, focuses on the development of selective immunosuppressive therapy. This novel class of drugs specifically suppresses the immune system…


Prof. Peter Scheiffele participates in EU-funded research project CANDY

The European funded research project CANDY investigates the underlying mechanisms of co-morbidities in neurodevelopmental diseases. “By looking at the mechanisms underpinning neurodevelopmental disorders it is our aim to…


Continued funding for Allen Discovery Center

How does a complex organism with a large number of different cells develop from a single cell? What are the common ancestors of the individual cells and how are they related to each other? What are the signals that drive the…